Dicerna Pharmaceuticals (NASDAQ:DRNA) saw an uptick in trading volume on Friday after the company announced better than expected quarterly earnings, American Banking & Market Newsreports. 357,389 shares were traded during mid-day trading, an increase of 103% from the previous session’s volume of 176,045 shares. Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) shares after opening at $26.58 moved to $27.22 on last trade day and at the end of the day closed at $25.21. Company price to sales ratio in past twelve months was calculated as 71.07 and price to cash ratio as 8.19. Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) showed a negative weekly performance of -21.71%.
Spherix Inc (NASDAQ:SPEX) has since lost some ground on the stock market, largely due to a dud volume-based transactions at the end of trading session. Spherix Inc (NASDAQ:SPEX) shares fell -4.98% in last trading session and ended the day on $2.86. SPEX return on equity ratio is recorded as -550.40 % and its return on assets is -373.10%. Spherix Inc (NASDAQ:SPEX) yearly performance is -59.60%.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) has an annual cash incentive program, which is designed to provide cash bonus awards to the Company’s employees, including the Company’s executive officers. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares moved down -3.23 % in last trading session and was closed at $1.50 while trading in range of $1.47 – $1.55 – AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) year to date (YTD) performance is -18.03%.
Clifton Savings Bancorp (NASDAQ:CSBK) Director Stephen Adzima acquired 26,000 shares of the stock in a transaction dated Tuesday, April 1st. The stock was purchased at an average price of $10.00 per share, for a total transaction of $260,000.00. Clifton Savings Bancorp, Inc. (NASDAQ:CSBK) weekly performance is -1.61%. On last trading day company shares ended up $11.61. Clifton Savings Bancorp, Inc. (NASDAQ:CSBK) distance from 50-day simple moving average (SMA50) is -8.99%. Analysts mean target price for the company is $14.00.
Leave a Reply